Cerus reported $164.67M in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Atrion ATRI:US 136.57M 2.8M
Cerulean Pharma CERU:US $ 47.82M 7.48M
Cerus CERS:US $ 164.67M 8.14M
Cytori Therapeutics CYTX:US $ 18.89M 3.22M
Haemonetics HAE:US $ 756.03M 26.58M
Meridian Bioscience VIVO:US $ 212.47M 5.09M
Nuvasive NUVA:US $ 823.31M 31.1M
Orasure Technologies OSUR:US $ 268.36M 20.07M
Quidel QDEL:US $ 1559.1M 554.55M
Sientra SIEN:US 134.94M 5.84M
Staar Surgical STAA:US $ 273.9M 2.49M
Terumo 4543:JP Y 558713M 14869M
Utah Medical Products UTMD:US $ 78.95M 3.11M